Chen, C.-H.; Kao, H.-J.; Yu, C.-L.; Weng, T.-H.; Huang, T.-T.; Huang, K.-Y.; Weng, S.-L.
Transcriptomic Evidence of Immune–Tumor Uncoupling Defines a High-Risk State in Uterine Corpus Endometrial Carcinoma. Int. J. Mol. Sci. 2026, 27, 4170.
https://doi.org/10.3390/ijms27104170
AMA Style
Chen C-H, Kao H-J, Yu C-L, Weng T-H, Huang T-T, Huang K-Y, Weng S-L.
Transcriptomic Evidence of Immune–Tumor Uncoupling Defines a High-Risk State in Uterine Corpus Endometrial Carcinoma. International Journal of Molecular Sciences. 2026; 27(10):4170.
https://doi.org/10.3390/ijms27104170
Chicago/Turabian Style
Chen, Chia-Hung, Hui-Ju Kao, Chen-Lin Yu, Tzu-Hsiang Weng, Tsung-Tao Huang, Kai-Yao Huang, and Shun-Long Weng.
2026. "Transcriptomic Evidence of Immune–Tumor Uncoupling Defines a High-Risk State in Uterine Corpus Endometrial Carcinoma" International Journal of Molecular Sciences 27, no. 10: 4170.
https://doi.org/10.3390/ijms27104170
APA Style
Chen, C.-H., Kao, H.-J., Yu, C.-L., Weng, T.-H., Huang, T.-T., Huang, K.-Y., & Weng, S.-L.
(2026). Transcriptomic Evidence of Immune–Tumor Uncoupling Defines a High-Risk State in Uterine Corpus Endometrial Carcinoma. International Journal of Molecular Sciences, 27(10), 4170.
https://doi.org/10.3390/ijms27104170